CD44 and cancer: We observed enrichment of human embryonic stem cell pluripotency genes along with transcriptional regulation of pluripotent stem cells that might lead to activation of POU5F1 (OCT4), SOX2, CD44, NANOG, and other genes associated with self-renewal and drug resistance of cancer cells.